
    
      A screening examination will be performed within 28 days prior to dosing. Eligible subjects
      will return to the study center in the morning of Day -1 and will remain in-patient until
      discharge about 98 hours after dosing (after oral glucose tolerance test in the morning of
      Day 5) if there are no safety issues. The s.c. injection will be administered in the morning
      of Day 1. Ambulatory visits will take place on Days 7, 9 and 12. A follow-up visit will take
      place on Day 15 and a final visit on Day 28.
    
  